For many patients with advanced renal cell carcinoma, breast cancer, or neuroendocrine tumors, targeted therapy represents a critical source of hope—helping to extend survival and control disease progression. 💰 Yet before that hope can be…
On March 8, 2023, China’s National Medical Products Administration (NMPA) announced a significant glumetinib approval—the conditional market authorization of the Class 1 innovative drug Glumetinib Tablets (brand name: Hai Yi Tan®), developed by Shanghai HaiHe Pharmaceutical.…
Nasopharyngeal carcinoma (NPC) was once regarded as a mysterious regional disease, as its incidence was exceptionally high in southern China, Southeast Asia, and other regions—particularly in Guangdong Province, China—leading to its historical designation as “Guangdong…
In the field of autoimmune disease treatment, 2021 marked a significant milestone—the world’s first-in-class dual-target biologic drug Telitacicept (brand name: Tai Ai®), independently developed in China, was officially approved for marketing for the treatment of…
IgA nephropathy is the most common primary glomerular disease in China, accounting for approximately 40%–50% of all primary glomerulonephritis cases. For many years, the treatment of IgA nephropathy has primarily relied on supportive therapies, especially…
🤔 When well-defined red patches covered in silvery-white scales appear on the skin, it is often more than just a cosmetic concern—it reflects a “microscopic war” being waged on the skin’s surface. Plaque psoriasis is…
🤔 In China, what is the most common primary glomerulonephritis leading to kidney failure in young and middle-aged adults? The answer is primary IgA nephropathy. 👉 This disease has an insidious onset, often presenting initially…
For decades, “Made in China” in pharmaceuticals conjured images of generic drugs and manufacturing scale. Today, that narrative is obsolete. A quiet revolution is reshaping the global biotech landscape, driven by China’s emergence as a…
🫁 Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory condition characterized by persistent airflow limitation and chronic airway inflammation. 🤔 Today, COPD remains a major global health challenge and continues to place a growing…
Primary hypertension remains one of the most widespread chronic conditions globally. 👉 Currently, approximately 1.2 billion adults are affected by hypertension globally, yet only about 23% achieve blood pressure control targets (<140/90 mmHg). 👉 Among…
In the fast-evolving landscape of lung cancer treatment, targeted therapies have reshaped the meaning of “precision medicine.” But long before today’s new-generation drugs took center stage, several pioneering therapies laid the foundation for modern targeted…
Cancer remains one of the most significant global health challenges, affecting millions of people every year. And cancer treatment often meant pain, suffering, and uncertainty. Today, however, oncology is being rapidly reshaped by technological innovation—from…
